ANTI-MALARIAL DRUGS MARKET ANALYSIS

Anti-malarial Drugs Market, By Drug Class (Aminoquinolines, Quinoline-methanol (4-quinolinemethanols), Cinchona Alkaloids, Biguanides, Sulfonamides and Sulfones, and Others), By Route of Administration (Oral and Injectable), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Published In : Jun 2023
Code : CMI3726
Pages :162
Formats :
Excel and PDF
Industry : Pharmaceutical

Regional Analysis

Global Anti-malarial Drugs Market- Regional Analysis

Among regions, Asia pacific is estimated to hold 24.1% of the market share in 2023. The Asia Pacific anti-malarial drug market is expected to witness significant growth in the coming years, driven by factors such as the increasing prevalence of malaria, and the rising demand for research and development for the malarial treatment. Thus, the rise in anti-malarial drugs market growth over the forecast period.

Geographies covered:

North America: U.S. and Canada
Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
Middle East: GCC Countries, Israel, and Rest of Middle East
Africa: South Africa, North Africa, and Central Africa